/Companies

Fina Biosolutions

Rockville, US · Maryland LLC

Find your way into Fina Biosolutions

Sign up to see every warm intro you have to Fina Biosolutions

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Fina Biosolutions team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Fina BioSolutions produces CRM197 carrier proteins used in vaccine development and research, offering both research-grade and cGMP-certified versions through an efficient E. coli expression system.

Founders & leadership

AL
Andrew LeesCEO and Chief Scientific Officer

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 1 round · 2024

▶$3MraisedNov 2024 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew LeesExecutive Officer, Director
Offering amount
$3M
Amount sold
$3M
First sale
Nov 2024
Incorporated
Limited Liability Company, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Fina Biosolutions.

Frequently asked questions

What does Fina Biosolutions do?
Fina BioSolutions produces CRM197 carrier proteins used in vaccine development and research, offering both research-grade and cGMP-certified versions through an efficient E. coli expression system.
How much funding has Fina Biosolutions raised?
Fina Biosolutions has disclosed $3M raised across 1 round.
Where is Fina Biosolutions headquartered?
Fina Biosolutions is headquartered in Rockville, US.